Staying Ahead of SEIS & EIS Funding Waves
The UK early‐stage scene is buzzing. SEIS (Seed Enterprise Investment Scheme) and its big brother EIS (Enterprise Investment Scheme) are at the heart of a wave of tax-advantaged rounds. Founders are lining up for generous reliefs, while investors hunt for the next disruptor. And yes, that’s where a smart EIS funding platform can make all the difference—matching capital to opportunity in minutes, not months.
This article dives into the latest rounds—like Mogrify’s $16 million Series A—and breaks down why now is prime time for SEIS and EIS. Plus, we’ll show how Oriel IPO helps both sides navigate the maze, from curated deal flow to commission-free fundraising. Explore how this EIS funding platform is revolutionising investment opportunities in the UK
What’s Fueling the Current SEIS & EIS Boom?
The UK government didn’t pull its punches when it launched SEIS and EIS. With tax reliefs up to 50 %, these schemes have supercharged early-stage investing. Suddenly, angel investors see a safety net. Founders see real capital. Here’s why the boom continues:
- Deep Tax Breaks: Up to 50 % income tax relief on SEIS and 30 % on EIS investments.
- Capital Gains Relief: No tax on gains if you hold qualifying shares for three years.
- Loss Relief: Offset losses against your income tax bill.
- Flexible Checkpoints: Rolling deployments let startups raise in multiple rounds.
Yet navigating HMRC rules can feel like solving a Rubik’s cube blindfolded. That’s why more people are turning to a dedicated EIS funding platform—one that handles compliance, vetting and connects you with investors who get your sector.
Mogrify’s $16 Million Series A: A Case Study
Mogrify Ltd, a Cambridge-based biotech, raised an additional $16 million on top of its earlier seed round. That brings its total funding to over $20 million. The round closed in October 2019, led by Ahren Innovation Capital, with strong backing from Parkwalk and 24Haymarket. Why does it matter?
- Deep Science: Mogrify’s direct cellular conversion tech can turn any mature human cell type into another without going via a stem cell phase.
- Strategic Investors: Ahren Innovation Capital and Parkwalk bring both capital and domain expertise.
- Growth Plan: Funds will accelerate internal cell therapy R&D and out-license novel IP.
It’s a textbook example of how targeted EIS funding can propel a deep-tech startup. Yet securing those investors isn’t automatic—you need visibility, credibility and a clear route to tax reliefs. That’s exactly what Oriel IPO offers: a vetted marketplace where high-potential startups like Mogrify stand out to the right angels.
Broadening the Landscape: Other Notable Rounds
While Mogrify grabs the headlines, SEIS and EIS have powered dozens of emerging ventures across sectors:
- A London-based fintech startup captured a £1 million SEIS round to scale its payment API.
- An agri-tech firm secured EIS backing to pilot autonomous crop drones.
- A green energy platform closed a mixed SEIS/EIS round to launch its urban solar project.
The beauty? These schemes are sector-agnostic. From life sciences to clean tech, if you tick the criteria, doors open. And you don’t need to sift through thousands of applications—that’s what a specialist EIS funding platform does for you, triaging and showcasing the most promising deals.
Why Oriel IPO Stands Out as an EIS Funding Platform
Not all platforms are built the same. Here’s why Oriel IPO has found its niche:
- Commission-Free Model
Keep more of what you raise. No hidden cuts. - Curated Opportunities
Every startup is vetted against SEIS/EIS HMRC rules. - Transparent Subscription Fees
Predictable costs. No nasty surprises. - Educational Tools
Guides, webinars and checklists to demystify tax reliefs. - Angel Matchmaking
Connect with investors who have sector expertise.
Compare that to generic crowdfunding sites. Seedrs and Crowdcube throw open the doors to hundreds of pitches—great for volume, less ideal if you want specialist EIS expertise. With Oriel IPO, founders get laser-focused exposure to angels hungry for your sector, while investors browse a gallery of compliance-checked opportunities.
Start using the EIS funding platform that puts founders first
Practical Tips for Founders on Landing EIS Backing
Securing SEIS/EIS cash isn’t just about a slick pitch deck. Here’s how to make your application bullet-proof:
- Nail Your Story
Be crystal clear on product-market fit and why you need SEIS/EIS now. - Gather Your Docs
Articles of association, cap table, and HMRC advance assurances—have them ready. - Leverage Education
Use Oriel IPO’s webinars and templates to avoid rookie mistakes. - Showcase Traction
Even early KPIs—beta users, LOIs—build investor confidence. - Communicate Early
Talk to angels before you launch the round. Get feedback, refine your offer.
These steps slash delays and boost your chances of a successful close. A well-prepared round on a specialist EIS funding platform virtually sells itself.
How Investors Can Use an EIS Funding Platform to Diversify Portfolios
Investing under SEIS/EIS can be daunting. But with the right platform, it feels almost fun:
- Tax Relief Calculator
Instantly see your net exposure after reliefs. - Sector Filters
Target deep-tech, fintech or biotech only. - Due Diligence Packets
Download pitch decks, financials and legal checks in one click. - Community Insights
Join webinars and Q&As with founders and co-investors. - Automated Alerts
Get notified when a new SEIS/EIS deal matches your criteria.
Ultimately, you want a platform that handles the paperwork and leaves you to pick winners. Oriel IPO’s approach means you spend time on diligence, not admin—exactly what a busy angel needs.
What Investors Are Saying
“Oriel IPO streamlined our first EIS round. The platform’s vetting saved us weeks of due diligence and unlocked tax benefits we didn’t even know existed.”
— Emma Clarke, Angel Investor“As a founder, I dreaded the HMRC paperwork. Oriel’s educational guides and checklists made it painless. We closed our SEIS raise in under two weeks.”
— Samuel Bennett, CEO, MedTech Innovate
Conclusion: Seize the Next Wave of SEIS & EIS Investments
SEIS and EIS remain cornerstones of the UK’s startup ecosystem. From biotech breakthroughs at Mogrify to the next AI disruptor, tax-advantaged rounds are where real momentum lies. The catch? You need a specialist, commission-free, and educationally rich EIS funding platform to cut through the noise.
Don’t let complex forms and scattered investor networks slow you down. Whether you’re launching your first seed round or browsing for deals, Oriel IPO’s online investment marketplace has you covered from end to end. Discover the EIS funding platform that’s changing the UK startup scene
